Select Medical (SEM) Soars 8.4%, Traders Snap up Shares Ahead of Delisting

We recently published The 10 Biggest Winners in a Bloody Market. Select Medical Holdings Corp. (NYSE:SEM) was one of the best performers on Tuesday.

Select Medical extended its winning streak to a sixth consecutive day on Tuesday, jumping 8.40 percent to finish at $16.26 apiece, as investors gobbled up shares following news that it is set to go private for a transaction worth $3.9 billion.

In a statement, Select Medical Holdings Corp. (NYSE:SEM) said that it entered into a definitive agreement, under which a consortium led by its Executive Chairman Robert Ortenzio and Senior Executive Vice President Martin Jackson would acquire all of the company’s outstanding shares at a price of $16.50 apiece.

The merger agreement was unanimously approved by the disinterested members of the company’s board of directors.

The transaction is expected to close in the middle of the year, subject to closing conditions, including the approval of its shareholders.

In other news, Select Medical Holdings Corp. (NYSE:SEM) is set to distribute $0.0625 dividends per share to all shareholders on record as of March 2, 2026, payable on March 12.

The dividends followed the company’s earnings performance last year, having swung to a net income attributable to shareholders of $20.17 million from a $16.05 million net loss in 2024. Total revenues grew by 7.7 percent to $1.4 billion from $1.3 billion year-on-year.

While we acknowledge the potential of SEM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.